Cavo M - Search Results

1

Role of consolidation therapy in transplant eligible multiple myeloma patients.

Cavo M, Brioli A, Tacchetti P, Zannetti BA, Mancuso K, Zamagni E. Cavo M, et al. Semin Oncol. 2013 Oct;40(5):610-7. doi: 10.1053/j.seminoncol.2013.07.001. Semin Oncol. 2013. PMID: 24135406 Review.

2

Allogeneic bone marrow transplantation in multiple myeloma.

Tura S, Cavo M. Tura S, et al. Among authors: cavo m. Hematol Oncol Clin North Am. 1992 Apr;6(2):425-35. Hematol Oncol Clin North Am. 1992. PMID: 1582983 Review.

3

M-2 protocol for melphalan-resistant and relapsing multiple myeloma.

Cavo M, Galieni P, Tassi C, Gobbi M, Tura S. Cavo M, et al. Eur J Haematol. 1988 Feb;40(2):168-73. doi: 10.1111/j.1600-0609.1988.tb00816.x. Eur J Haematol. 1988. PMID: 3345830

4

Allogeneic bone marrow transplantation for the treatment of multiple myeloma. An overview of published reports.

Cavo M, Benni M, Cirio TM, Gozzetti A, Tura S. Cavo M, et al. Stem Cells. 1995 Aug;13 Suppl 2:126-31. doi: 10.1002/stem.5530130720. Stem Cells. 1995. PMID: 8520501 Review.

5

The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myeloma.

Cavo M, Benni M, Gozzetti A, Tura S. Cavo M, et al. Baillieres Clin Haematol. 1995 Dec;8(4):795-813. doi: 10.1016/s0950-3536(05)80260-4. Baillieres Clin Haematol. 1995. PMID: 8845573 Review.

6

Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.

Lemoli RM, Cavo M, Fortuna A. Lemoli RM, et al. Among authors: cavo m. J Hematother. 1996 Aug;5(4):339-49. doi: 10.1089/scd.1.1996.5.339. J Hematother. 1996. PMID: 8877709 Clinical Trial.

7

Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.

Zinzani PL, Bendandi M, Magagnoli M, Rondelli D, de Vivo A, Benni M, Zamagni E, Cavo M, Tura S. Zinzani PL, et al. Among authors: cavo m. Eur J Haematol. 1997 Aug;59(2):82-8. doi: 10.1111/j.1600-0609.1997.tb00730.x. Eur J Haematol. 1997. PMID: 9293855 Clinical Trial.

8

Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma.

Lemoli RM, Fortuna A, Raspadori D, Ventura MA, Martinelli G, Gozzetti A, Leopardi G, Ratta M, Cavo M, Tura S. Lemoli RM, et al. Among authors: cavo m. Leuk Lymphoma. 1997 Dec;26 Suppl 1:1-11. doi: 10.3109/10428199709058595. Leuk Lymphoma. 1997. PMID: 9570675 Review.

9

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma.

Cavo M, Bandini G, Benni M, Gozzetti A, Ronconi S, Rosti G, Zamagni E, Lemoli RM, Bonini A, Belardinelli A, Motta MR, Rizzi S, Tura S. Cavo M, et al. Bone Marrow Transplant. 1998 Jul;22(1):27-32. doi: 10.1038/sj.bmt.1701280. Bone Marrow Transplant. 1998. PMID: 9678792

10

In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells.

Tosi P, Pellacani A, Visani G, Ottaviani E, Ronconi S, Zamagni E, Benni M, Cavo M, Tura S. Tosi P, et al. Among authors: cavo m. Eur J Haematol. 1999 Mar;62(3):143-8. doi: 10.1111/j.1600-0609.1999.tb01736.x. Eur J Haematol. 1999. PMID: 10089890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters